Comparison Overview
Novartis Norge

Novartis Norge
Nydalen allé 37, Nydalen, Oslo, 0484, NO
Last Update: 14/11/2025
Novartis er et nytenkende legemiddelselskap. Vi er først ute med nyskapende celle- og genterapier i Norge. Vi forsker og utvikler legemidler innen et bredt spekter av terapiområder, som kreft, kroniske- og sjeldne sykdommer. Vi er stolte av å være en konstruktiv samarbe...

Lonza
Muenchensteinerstr. 38, Basel, CH, 4002
Last Update: 01/04/2026
Lonza is a pioneer and world leader in the CDMO industry, setting the pace with cutting-edge science, smart technology, and lean manufacturing. United by a common purpose, we turn our customers’ breakthrough innovations into viable therapies and manufacture the medicine...
Compliance Ranges Comparison

Novartis Norge







Lonza






Benchmark & Cyber Underwriting Signals
Incidents vs Pharmaceutical Manufacturing Industry Avg (This Year)
No incidents recorded for Novartis Norge in 2026.
Incidents vs Pharmaceutical Manufacturing Industry Avg (This Year)
No incidents recorded for Lonza in 2026.
Incident History - Novartis Norge (X = Date, Y = Severity)
Novartis Norge cyber incidents detection timeline including parent company and subsidiaries.
Incident History - Lonza (X = Date, Y = Severity)
Lonza cyber incidents detection timeline including parent company and subsidiaries.
Notable Incidents

Novartis Norge

Lonza
FAQ
Latest Global CVEs
Pcapng file parser crash in 4.6.0 to 4.6.7 and 4.4.0 to 4.4.18 allows denial of service
X.509IF protocol dissector crash in 4.6.0 to 4.6.7 and 4.4.0 to 4.4.18 allows denial of service
H.245 protocol dissector crash in 4.6.0 to 4.6.7 and 4.4.0 to 4.4.18 allows denial of service
BUSMASTER file parser abnormal exit in 4.6.0 to 4.6.7 and 4.4.0 to 4.4.18 allows denial of service
Kerberos protocol dissector crash in 4.6.0 to 4.6.7 and 4.4.0 to 4.4.18 allows denial of service